News
In 2018, the former leadership of team from Kite Pharma founded Allogene ... "In comparison to autologous CARTs, allo-CART, or ‘off-the-shelf’ CART therapies have a unique advantage in ...
4d
MedPage Today on MSNHigh Response Rate in Myeloma With Novel CAR-T After Anti-BCMA FailureOver 80% of patients with relapsed/refractory multiple myeloma responded to anti-GPRC5D CAR T-cell therapy after failure of anti-BCMA CAR T-cell therapy. The investigational therapy showed superior ...
Gilead Sciences’ Kite Pharma unit is closing on approval of its second European approval for a CAR-T for cancer, after the CHMP backed its KTE-X19 therapy for mantle cell lymphoma.
BELCO was notified of the outage and on arrival, the overhead line crew found a member of public whose kite and line had become entangled in the overhead network. “When attempting to free the ...
Belco said 821 customers were in the dark for just over an hour when a member of the public, whose kite hit the overhead wires on Good Friday, attempted to disentangle it by tugging on the string ...
At the Standalone during the January to March 2025 quarter, the Sudarshan Pharma Industries net profit at ₹9.95 crore also saw a sharp rise The net profit for the quarter reported buy the ...
The annual Kite Fest Louisiane takes off at 11 a.m. Saturday at the West Baton Rouge Soccer Complex, 3383 Rosedale Road, Port Allen. Competitions, retailers, design-a-kite, candy shower ...
LONDON, April 25 (Reuters) - A 25% U.S. tariff on pharmaceutical imports would increase U.S. drug costs by nearly $51 billion annually, boosting U.S. prices by as much as 12.9% if passed on, a ...
Gilead has thrown plenty of money at its oncology division - for example, the $21bn acquisition of Immunomedics, $4.9bn buyout of Forty Seven, and $12bn paid for Kite Pharma, yet in Q1 the ...
It comes as the heads of 30 pharma companies in the industry warned of an “exodus” of future investment in a letter to European Commission president Ursula von der Leyen. Picture: Anadolu ...
We also bring on STAT’s European correspondent Drew Joseph to talk about the growth of pharma manufacturing in Ireland and how U.S. tariffs would impact global drug supply. Elaine Chen covers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results